Price Alert

Regencell Bioscience Lim... (RGC)

NASDAQ: RGC · Real-Time Price · USD

12.69

-0.63 (-4.77%)

At close: Aug 19, 2025, 11:57 AM

-4.77% (1D)

Bid	12.65
Market Cap	6.27B
Revenue (ttm)	n/a
Net Income (ttm)	-4.09M
EPS (ttm)	-0.01
PE Ratio (ttm)	-1268.77
Forward PE	n/a
Analyst	n/a

Ask	12.84
Volume	92,098
Avg. Volume (20D)	1,465,267
Open	13.04
Previous Close	13.32
Day's Range	12.55 - 13.16
52-Week Range	0.09 - 83.60
Beta	2.19

About RGC

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol RGC

Website n/a

Full Company Profile

Why Price Moved

2 months ago

+283.14%

Regencell Bioscience shares are trading higher. Th... Unlock content with Pro Subscription

2 months ago

-14.73%

Regencell Bioscience shares are trading lower after the company announced a 38-for-1 forward stock split.

News

1 week ago · seekingalpha.com

RGC Resources: The Impact Of MVP

RGCO is entering a high cash flow phase from past investments, notably with the Mountain Valley Pipeline now operational, supporting a strong buy rating. Q2 2025 results exceeded expectations, marking...

2 weeks ago · fool.com

1 Magnificent Stock-Split Stock to Buy Hand Over Fist in August and 1 to Absolutely Avoid

For more than three decades, investors have consistently had a next-big-thing technology or trend to captivate their attention and wallets. For instance, artificial intelligence (AI) has been a drivin...

1 month ago · fool.com

1 Magnificent Stock-Split Stock to Buy Hand Over Fist in July and 1 to Completely Avoid

Though artificial intelligence (AI) has been the hottest innovation on Wall Street for well over two years, it's not the only trend that's helped power Wall Street's major stock indexes to record-clos...

2 months ago · fool.com

Prediction: Wall Street's Latest Stock-Split Stock -- Up 60,120% Year-to-Date -- Is Going to Implode

Since the S&P 500's bull market began in October 2022, no trend has provided a bigger lift to equities than the evolution of artificial intelligence (AI). In Sizing the Prize, the analysts at PwC esti...

2 months ago · invezz.com

This stock with no revenue surges 64,000% in a year: find out why

Regencell Bioscience Holdings, a biotech company focused on herbal medicine, has gained over 400% on Monday and over 64,000% in the past year. This growth in stock price is despite the company not hav...